loader image
Friday, December 19, 2025
77.5 F
McAllen
- Advertisement -

AFib Is 3 Times More Widespread Than Doctors Thought

Translate to Spanish or other 102 languages!

Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
- Advertisement -

New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had previously estimated. Image credit: Keith Brofsky/Getty Images.

  • Previous studies have reported that about 3 million people in the United States have atrial fibrillation (AFib). 
  • Researchers from the University of California – San Francisco discovered that AFib is three times more common in the U.S. than previously thought.
  • Over the course of the study, scientists found that people with AFib tended to be younger, less likely to be female, and more likely to have high blood pressure and diabetes.

Follow the link to Medical News Today for the full story:

https://www.medicalnewstoday.com/articles/afib-is-3-times-more-widespread-than-doctors-thought

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×